Cutera Stock Forecast, Price & News

+0.83 (+1.62 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume121,554 shs
Average Volume187,931 shs
Market Capitalization$924.71 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

Cutera logo

About Cutera

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, myQ, and skincare products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.91 out of 5 stars

Computer And Technology Sector

477th out of 1,646 stocks

Electromedical Equipment Industry

17th out of 64 stocks

Analyst Opinion: 1.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cutera (NASDAQ:CUTR) Frequently Asked Questions

Is Cutera a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cutera stock.
View analyst ratings for Cutera
or view top-rated stocks.

What stocks does MarketBeat like better than Cutera?

Wall Street analysts have given Cutera a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cutera wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cutera's next earnings date?

Cutera is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Cutera

How can I listen to Cutera's earnings call?

Cutera will be holding an earnings conference call on Wednesday, August 4th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its earnings results on Wednesday, May, 5th. The medical device company reported ($0.02) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.19) by $0.17. The medical device company had revenue of $49.67 million for the quarter, compared to the consensus estimate of $39.50 million. Cutera had a negative trailing twelve-month return on equity of 23.29% and a negative net margin of 7.16%.
View Cutera's earnings history

How has Cutera's stock been impacted by COVID-19?

Cutera's stock was trading at $18.11 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CUTR stock has increased by 186.9% and is now trading at $51.95.
View which stocks have been most impacted by COVID-19

What price target have analysts set for CUTR?

3 Wall Street analysts have issued 12-month price targets for Cutera's shares. Their forecasts range from $24.00 to $60.00. On average, they anticipate Cutera's share price to reach $42.00 in the next twelve months. This suggests that the stock has a possible downside of 19.2%.
View analysts' price targets for Cutera
or view top-rated stocks among Wall Street analysts.

Who are Cutera's key executives?

Cutera's management team includes the following people:
  • Mr. J. Daniel Plants, Exec. Chairman (Age 54, Pay $83.29k)
  • Mr. David H. Mowry, CEO & Director (Age 59, Pay $661.56k)
  • Mr. Rohan Seth, Chief Financial Officer (Age 43, Pay $263.89k)
  • Dr. Michael Karavitis, Exec. VP & Chief Technology Officer
  • Anne Werdan, Director of Investor Relations

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera CEO David H. Mowry on David H. Mowry has an approval rating of 100% among Cutera's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cutera's key competitors?

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Square (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by many different institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (0.54%), Monarch Partners Asset Management LLC (0.32%) and State of Alaska Department of Revenue (0.07%). Company insiders that own Cutera stock include David H Mowry, J Daniel Plants and Katherine S Zanotti.
View institutional ownership trends for Cutera

Which major investors are selling Cutera stock?

CUTR stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC.
View insider buying and selling activity for Cutera
or view top insider-selling stocks.

Which major investors are buying Cutera stock?

CUTR stock was purchased by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, and State of Alaska Department of Revenue. Company insiders that have bought Cutera stock in the last two years include David H Mowry, J Daniel Plants, and Katherine S Zanotti.
View insider buying and selling activity for Cutera
or or view top insider-buying stocks.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $51.95.

How much money does Cutera make?

Cutera has a market capitalization of $924.71 million and generates $147.68 million in revenue each year. The medical device company earns $-23,880,000.00 in net income (profit) each year or ($1.43) on an earnings per share basis.

How many employees does Cutera have?

Cutera employs 323 workers across the globe.

What is Cutera's official website?

The official website for Cutera is

Where are Cutera's headquarters?

Cutera is headquartered at 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]

This page was last updated on 8/1/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.